Answer
Cholesterol-related diseases are primarily targeted by statin drugs developed from the studies of Goldstein and Brown. These drugs work by blocking the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol. This leads to a decrease in the amount of cholesterol in the blood, which can help to reduce the risk of heart disease, stroke, and other cardiovascular problems.